The effect of oral Clonidine on the treatment of diabetic neuropathy.
Phase 2
Recruiting
- Conditions
- Diabet- Diabetic neuropathy..Type 2 diabetes mellitus with diabetic neuropathy, unspecified.E11.40
- Registration Number
- IRCT20211106052983N1
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Patients with type 2 diabetes who have symptoms associated with peripheral neuropathy.
No chronic illness (cardiovascular, renal and thyroid disorders), severe neurology or psychiatry.
Do not be pregnant or breastfeeding.
Not taking medications that are effective in exacerbating or alleviating neuropathy.
Age between 30 and 60 years old.
Exclusion Criteria
Having severe sensitivity to Clonidine
Having neuropathy with proven reasons except Diabetes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of neuropathy in this study based on the Michigan Questionnaire, pain based on the McGill Pain Questionnaire. Timepoint: Before the start of the study and 14, 28, 56 days later. Method of measurement: The Michigan Questionnaire, the McGill Questionnaire, and the researcher-designed questionnaire.
- Secondary Outcome Measures
Name Time Method